02373.HK
Beauty Farm Medical and Health Industry Inc.
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 19.67
+10.51%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.3B | 3.0B | 2.6B | 2.1B | 1.6B |
| Cost of Revenue | 3.2B | 1.5B | 1.4B | 1.2B | 917.6M |
| Gross Profit | 3.1B | 1.5B | 1.2B | 977.1M | 717.8M |
| Operating Expenses | |||||
| R&D Expense | 83.0M | 41.9M | 36.0M | 34.1M | 31.2M |
| SG&A Expense | 2.1B | 992.7M | 849.8M | 166.9M | 171.1M |
| General & Admin Expense | 980.4M | 477.0M | 388.1M | 31.5M | 60.4M |
| Selling & Marketing Expense | 1.1B | 514.7M | 461.7M | 135.4M | 110.7M |
| Other Expenses | (40.1M) | (22.3M) | (17.7M) | 484.9M | 363.4M |
| Total Operating Expenses | 2.1B | 1.0B | 868.2M | 685.8M | 565.7M |
| Cost and Expenses | 5.4B | 2.5B | 2.3B | 1.9B | 1.5B |
| Operating Income (EBIT) | 952.8M | 459.5M | 321.8M | 291.3M | 152.1M |
| Non-Operating | |||||
| Interest Income | 36.3M | 22.7M | 23.6M | 21.8M | 3.1M |
| Interest Expense | 20.8M | 32.2M | 27.6M | 24.8M | 24.7M |
| Net Interest Income | (25.1M) | (9.4M) | (3.9M) | (3.0M) | (21.6M) |
| Other Non-Op Income/Expense | (25.2M) | (9.4M) | (3.9M) | (3.0M) | (21.6M) |
| Non-Operating Income (excl Interest) | 21.3M | 7.7M | 11.7M | (21.8M) | (3.1M) |
| EBT (Pre-Tax Income) | 927.6M | 450.1M | 317.9M | 288.3M | 130.5M |
| Income Tax Expense | 221.6M | 109.8M | 65.4M | 58.1M | 19.9M |
| Bottom Line | |||||
| Net Income | 652.8M | 317.6M | 228.5M | 215.7M | 103.1M |
| Earnings from Cont. Ops | 706.1M | 340.3M | 252.5M | 230.1M | 110.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 652.8M | 317.6M | 228.5M | 215.7M | 103.1M |
| Per Share | |||||
| Basic EPS | HK$2.77 | HK$1.38 | HK$0.99 | HK$0.94 | HK$0.45 |
| Diluted EPS | HK$2.77 | HK$1.37 | HK$0.99 | HK$0.94 | HK$0.45 |
| Revenue Per Share | HK$25.87 | HK$12.94 | HK$11.20 | HK$9.35 | HK$7.09 |
| Shares | |||||
| Basic Shares Outstanding | 244.1M | 231.8M | 229.8M | 229.4M | 230.6M |
| Diluted Shares Outstanding | 245.3M | 231.9M | 229.8M | 230.1M | 230.6M |
| Profitability Metrics | |||||
| EBITDA | 1.4B | 603.5M | 427.5M | 644.8M | 452.4M |
| D&A | 445.0M | 151.7M | 117.3M | 331.7M | 297.2M |
| EBIT | 931.5M | 451.8M | 310.1M | 313.1M | 155.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026